Patents by Inventor Harry Leider

Harry Leider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160252483
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: May 5, 2016
    Publication date: September 1, 2016
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20140287529
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In an embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing the measured drug level as a function of one or more parameters associated with the subject. The drug level can be normalized using second order quantile regression. Embodiments of the methods can use both primary and secondary metabolites in the normalization; allow changing variance by dose; allow asymmetry in variance above and below the estimated median values; and/or use analytic variables with stable estimates, such as, for example, variables associated with the percentile for ?1 standard deviation, the percentile for 0 standard deviation, and the percentile for +1 standard deviation.
    Type: Application
    Filed: March 17, 2014
    Publication date: September 25, 2014
    Applicant: AMERITOX, LTD.
    Inventor: Harry Leider
  • Publication number: 20130245960
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: May 8, 2013
    Publication date: September 19, 2013
    Applicant: AMERITOX, LTD.
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20110224910
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: February 11, 2011
    Publication date: September 15, 2011
    Applicant: AMERITOX, LTD.
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20110195521
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 11, 2011
    Applicant: Ameritox, Ltd.
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20110195520
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 11, 2011
    Applicant: AMERITOX, LTD.
    Inventors: Harry Leider, Ariel Linden